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Abstract: This analysis examines the roots of clinical practice regarding oxygen 
therapy and finds that some aspects have changed very in little over the past two 
hundred years. Oxygen is commonly prescribed and administered as a therapy 
across all healthcare settings; particularly for the treatment and management of 
respiratory conditions, both acute and chronic. Yet despite its widespread use and 
recent advances in understanding and guidance, poor practice and controversies 
regarding its use persist. This historical analysis highlights origins in practice that 
may suggest where the roots of these fallacies lie, highlighting potential ambiguities 
and myths that have permeated clinical and social contexts. It can be considered 
that based on clinical presumptions and speculation the prolific and injudicious use 
of oxygen was encouraged and the legacy for today’s practice seeded. The 
conjectures proposed here may enable modern day erroneous beliefs to be 
confronted and clinical practice to move on. 
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Introduction 
Oxygen therapy is one of the commonest interventions in modern day 
healthcare worldwide. Yet, despite universal use, it is evident through poor practice 
that oxygen is often prescribed and administered injudiciously; [O’Driscoll et al, 2011; 
Wallace et al, 2010; Pilcher et al, 2013] potentially resulting in worse outcomes for 
respiratory patients, including increased mortality particularly in the pre-hospital 
setting [Austin et al, 2010; Perrin et al, 2011; Wijesinghe et al, 2012]. Similarly, a 
report on domiciliary oxygen in the United Kingdom (UK) [Royal College of 
Physicians, 1999], demonstrated costly poor prescribing practices, leading to major 
changes in home oxygen services in England and Wales [British Thoracic Society 
(BTS), 2006].  
The issue of problematic prescribing in the United Kingdom (UK) has heralded 
directives from the National Patient Safety Agency [NPSA, 2009] which received 281 
reports of serious incidents related to oxygen, of which, poor oxygen management 
appears to have both caused and contributed to patient deaths. The number of 
unreported incidents cannot be assessed and the problem could be greater in the 
community. The use of oxygen in both acute and chronic settings is now recognised 
as a major area for improvement in England [Department of Health (DH), 2011]. 
When administered as a therapeutic intervention oxygen is regarded as a 
drug [British National Formulary (BNF), 2014]. In the UK contemporary guidelines 
offer criteria and directives for administration and prescription of oxygen, dependant 
on the patient’s condition, acuity and care setting [BTS, 2006; BTS, 2008; Joint 
Royal Colleges Ambulances Liaison Committee (JRCALC), 2013]. In the context of 
respiratory care, oxygen is generally prescribed for hypoxaemia, as either an acute 
or chronic therapy; the condition being treated would normally determine the 
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concentration and duration of oxygen administered. Despite these widely accepted 
guidelines however it is unclear why poor practice persists [BTS, 2008].  
It has been proposed that possibly an influencing culture presides, whereby 
oxygen is often poorly understood and uncertainty regarding its use exists [BTS, 
2008], leading, at times, to inappropriate use and prescription. Yet it is unclear where 
the origins of this existing culture lie. The problem may self-perpetuate as erroneous 
beliefs impact upon patients’, carers’ and the general public’s perceptions. Thus this 
analysis seeks to explore historical perspectives of oxygen in order to consider 
origins of practice that may influence and permeate contemporary healthcare. 
Highlighting these issues could help identify misplaced beliefs and allow healthcare 
practitioners to confront poor practice that is continuing to harm patients.   
The Context 
In order to contextualize the problem it is worth first considering the 
evolutionary nature of living organisms which adapted not only to utilise oxygen, but 
also to tolerate and provide protection against it. Oxygen, absent from the Earth’s 
atmosphere during its formation, latterly became abundant, rising to levels of 
approximately 35% about 300 million years ago, before falling and stabilizing to 
today’s 20.8%; the reason is attributed to photosynthesis. It is regarded that the 
evolutionary development of mitochondria, an inherited legacy from photosynthetic 
ancestors then enabled oxygen to be harnessed as an economic fuel allowing the 
evolution of complex organisms with high energy demands [Lane, 2002]. 
Paradoxically adaptation to aerobic respiration required additional adjustment 
to protect against oxygen’s toxic effects - namely reactive oxygen species (ROS). 
ROS are unstable molecules produced during normal metabolism. An excess of 
ROS results in oxidative stress which can be damaging to the body’s cells and has 
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been associated with aging [Dowling and Simmons, 2009]. The structure of the 
mitochondria themselves seems central to this protection: the mitochondria has its 
own DNA and reproduces independently of the host cell. It is thought that this 
primary evolutionary function of the compartmentalisation protects the cells’ nuclei 
from damaging toxic side effects of oxygen metabolism [Abele, 2002].  The sensitive 
equilibrium that mitochondria therefore aim to achieve is to keep cellular oxygen 
concentration high enough to meet the tissue’s demands but low enough to minimise 
or control ROS formation. Seemingly the evolutionary irony of oxygen is that in 
addition to sustaining life it is also what limits lifespan and ultimately kills.  
With increasing knowledge and understanding of these processes, a growing 
body of evidence is now highlighting the potential iatrogenic effects of oxygen, for 
example worsening hypercapnia,  in certain clinical conditions [Austin et al, 2010; 
Singhal, 2006; Shuvy et al 2013], often adding to healthcare professionals’ 
uncertainties and clinical quandaries. Uprooting the origins of these current beliefs 
and overthrowing the enigma that oxygen is the panacea of contemporary clinical 
practice will be an important step in confronting existing beliefs and myths. The 
history of oxygen may enlighten this challenge.  
Early discoveries  
Early founders recognised that air was made up of various components. In 
1674 Mayow termed ‘aerial nitre’ (oxygen) as a normal constituent of air, yet despite 
this seemingly accurate concept it took a further century to isolate oxygen. One of 
the key reasons for this delay was persistent belief in the ‘phlogiston theory’. In 1771 
Scheele and in 1775 Priestly both discovered oxygen independently. Both 
appreciated that burning (of candles) was more vigorous in the presence of oxygen 
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and Scheele termed ‘fire-air’ to depict the gas [Scheele, 1771] Priestly on the other 
hand named the gas ‘dephlogisticated air’ [Priestly, 1775]. The term originating from 
the accepted purporting that phlogiston, a contaminant, was released in combustion, 
therefore dephlogisticated air represented pure air. This theory dogma probably 
blinded both Scheele and Priestly to the true meaning of their discoveries and it 
wasn’t until 1777 that Antoine Lavoisier cast off the flawed theory and named oxygen 
as the reactive constituent of air [Grainge, 2004]. 
Despite the fetters that beliefs of the day imposed on Priestly, he recognised 
potential benefits of oxygen. In his words ‘... it may be conjectured, that it might be 
peculiarly salutary to the lungs in certain morbid cases’ [Priestly, 1775]. He also 
recognised collateral merits of oxygen as a placebo: ‘… I fancied my breast felt 
peculiarly light and easy for some time afterwards. Who can tell that, in time, this 
pure air may become a fashionable article in luxury’ [Priestly, 1775]. This insight into 
the use of oxygen as a commodity is unprecedented in contemporaneous and 
subsequent literature, but clearly parallel to today’s commercial oxygen industry.  
In addition to beneficial effects Priestley pondered the potential that oxygen 
may accelerate aging and death, not dissimilar to today’s free radical theory of aging:  
‘[oxygen] might not be so proper for us in the usual healthy state 
of the body; for, as a candle burns out much faster in [oxygen] than in 
common air, so we might, as may be said, live out too fast ... A 
moralist, at least, may say, that the air which nature has provided for 
us is as good as we deserve.’ [Priestly, 1775]   
Priestley alludes to the toxicity of oxygen but although it was embraced as 
medical therapy by Priestley’s contemporaries, its potentially noxious qualities were 
not documented further until 1849 when Lorrain Smith reported high oxygen tensions 
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acting as an irritant, inflaming lung tissue. Based on animal studies however, these 
latter findings were slow to be adopted.  
The first publication reporting oxygen as a medical therapy was in 1783; a 
French physician treating a young woman with tuberculosis claimed that she ‘very 
much benefitted’ [Grainge, 2004]. Soon after in 1798 the Pneumatic Institute opened 
in Bristol to investigate the efficacy of oxygen to treat disease. Thomas Beddoes, the 
founder of the institute was joined by Humphrey Davy and James Watt [Leigh, 1974]. 
These early experiments however proved unsuccessful, probably because of the 
ambitious choice of intractable diseases (including dropsy and venereal disease). 
Beddoes favored the notion that in some cases oxygen did good, and in others it 
could do no harm [Leigh, 1974]. This philosophy of oxygen as harmless has followed 
practice over the next 200 years.  
Quacks and Charlatans 
Throughout the 19th century problems with oxygen therapy persisted, probably 
due to impurities, lack of scientific knowledge and diverse delivery methods – for 
example bubbling oxygen through water and wafting it towards the patient [Grainge, 
2004]. Additionally, a lack of understanding of physiology often led to hyperbolic 
claims, further impeding scientific advancement.  
Much literature of the time purported virtues of oxygen therapy; the principle 
ethos being that oxygen is essential for life so it should be a treatment for all 
diseases. Birch in 1857 heralds the case of a 33 year old with syphilitic ulcerated 
legs exemplifying the curative nature of oxygen. The ‘largest quantity that could be 
borne’ was administered every evening and in three months his ulcerated legs were 
cured. In 1869 Birch further wrote about oxygen ‘in connexion [sic] with a new, 
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agreeable, and easy form of administration by the stomach’. What Birch was 
referring to was ‘oxygenated bread’. Heralding its merits he advocated ‘a surprisingly 
small bit of this oxygenated bread proves its special influences in suitable cases’ 
[Blodget, 1890]. Similar abundant claims for oxygen products can be found on the 
internet today. Preservation of the bread was problematic but Birch suggested using 
paper soaked in phenic acid to keep mould at bay: ‘... will prove a positive advantage 
to some patients who desire medical flavor’ [Birch, 1869]. Analogies with the placebo 
effect are apparent.  
Mixed messages   
Claims to success with specific diseases, for example pneumonia, appeared 
more trustworthy. In 1890 Albert Blodgett used oxygen to treat a 46 year old woman 
with pneumonia quoting ‘...the patient was irrevocably doomed, and the best result 
that I looked for was simply relief to the sensation of suffocation...’. But she 
recovered with continuous administration of oxygen. Blodgett correctly identified 
oxygen as ‘tiding the system over’ rather than curing disease [Blodgett, 1890]. 
Importantly he acknowledged the potential toxicity of oxygen: ‘Pure oxygen I believe 
to be too powerful an oxidizing agent when used alone, especially when there exists 
inflammation of the air passages’. ‘Judicious employment’ and stopping oxygen as 
soon as possible were advocated [Blodgett, 1890]. Unfortunately this early insight 
went unheeded and the toxicity of oxygen was, and often still is, overlooked.   
At the same time oxygen to treat dyspnoea was common. Dyspnoea can be 
defined as the subjective experience of discomfort in breathing. It is a complex 
symptom and a distressing sensation of both body and mind [Booth, 2013]. A 
common presentation of a wide range of diseases, it has been identified as a potent 
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predictor of mortality and hospitalization [Parshall et al, 2012]. It is now recognised 
that an array of physiological mechanisms in addition to psychological, social and 
environmental factors contribute to dyspnoea and the complexity itself adds to its 
often intractable nature. Given the limited knowledge however of physiology in the 
19th century it was hardly surprising that the sensation of breathlessness and lack of 
oxygen were often considered synonymous. An example published in 1891 by 
Robert Reed: ‘In general terms one may say any disease which gives rise to 
dyspnoea will be benefitted by oxygen, and the greater the dyspnoea the greater the 
need of oxygen’ [Anon, 1991]. A philosophy that appears to have traversed decades 
with little modification as many clinicians often believe that, with regards oxygen 
therapy, ‘more is better’. Additionally, given the complex psychological dimensions of 
dyspnoea, it is hardly surprising that if a medication is prescribed and administered it 
may have additional placebo effects. Recent evidence concludes that, although 
oxygen may alleviate breathlessness to some extent, the use of air provides similar 
relief (Abernethy et al, 2010; Cranston et al, 2008).  
Fick and Bert advanced understanding of related physiology further describing 
oxygen tension in terms of partial pressure [Haldane, 1917]. Building further on this 
work John Scott Haldane published ‘The therapeutic administration of oxygen’ in 
1917. This landmark paper represents the origin of rational use of oxygen, outlining 
regulation of respiratory drive by carbon dioxide and its effects on blood hydrogen 
concentrations and pH.  
Haldane’s legacy to respiratory medicine was prolific. Amongst his attributed 
discoveries he explained the physiology of carbon monoxide poisoning; proposed 
the need to know the percentage of oxygen administered, and the concept of 
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ventilation perfusion matching. Haldane also alluded to the toxicity of oxygen citing 
the work of Lorrain Smith [Haldane, 1919]. Haldane’s cautious advice was to give 
only as much oxygen as would ‘suffice to relieve anoxaemia ’[Haldane, 1919]; a 
further recognition of judicious employment of oxygen; a key message in today’s 
guidelines [BTS, 2008] that is still often not heeded.   
Enlightenment 
Throughout the 20th century use of oxygen as a therapy progressed. In part 
due to advances in science and medicine, but most profoundly experiences of gas 
poisoning in the First World War (1914-18). Phosgene was used commonly in the 
trenches and principally caused pulmonary oedema; oxygen therapy became the 
primary treatment.  
Empirical knowledge followed with single blind experiments showing oxygen 
improved survival and reduced morbidity. Intermittent use of oxygen however, for 
example five minutes in each hour, was still common practice although condemned 
as ‘useless’ [Royal Society of Medicine, 1920]. It seems that ambiguity regarding the 
clinical use of PRN oxygen was established. 
Still, physiological understanding progressed. In 1920 Meakins published 
experimental work in the BMJ outlining methods for calculating percentage of oxygen 
saturation of haemoglobin and its relationship to the patient’s condition. Meakins, a 
physiologist, however neglected clinical outcomes of treatment and robust studies 
failed to materialise.  
The sound scientific basis for oxygen therapy was definitively proposed in 
1922 by Haldane in ‘Respiration’. Haldane highlighted the principles of knowing the 
percentage of oxygen breathed, keeping it as low as possible, and balancing the 
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risks of hypoxia and hyperoxia [Haldane, 1922]; the same key principles that guide 
oxygen administration today [BTS, 2008] but which are seldom heeded [Austin, 
2010].   
Reluctance to use continuous oxygen however still pervaded practice. In an 
attempt to confront this poor practice Haldane reportedly summarised intermittent 
use as ‘... bringing a drowning man to the surface of the water – occasionally’ 
[Campbell, 1965]; Campbell in 1965 offered a contrary perspective: ‘it is like pushing 
him down between times’. Campbell went on to describe use of intermittent oxygen 
as ‘... bad practice which I think and hope is disappearing’. Almost fifty years on 
Campbell would surely be disappointed with common clinical practice of PRN 
oxygen.  
Cautionary tales  
Simultaneously, as the issue of controlling oxygen doses was debated, the 
widespread use of 100% oxygen was endorsed. Boothby et al in 1939 reported ‘The 
ability to administer practically 100 per cent oxygen ... economically, efficiently and 
comfortably, has opened a new field.’ Based on preventative principles, 100% 
oxygen was administered to all patients following extensive surgery. Additionally, 
relief of headaches, seasickness, acute pulmonary oedema and angina were 
indicated, ‘...without the slightest evidence of pulmonary irritation’ [Boothby et al, 
1939]. Although claims were cautioned by those aware of oxygen toxicity, current 
practice suggests this caveat was seldom heeded and the practice of administrating 
high flow oxygen to treat most clinical presentations was established and persists 
today.    
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It has been recognised for several decades now that oxygen administration 
can cause CO2 levels to increase significantly and that inappropriate use of oxygen 
in some patients can be harmful [Donald, 1949]. The importance of titrating oxygen 
to achieve target saturation ranges has become increasingly apparent, with a 
number of randomised controlled trials indicating that failure to do so in patients 
presenting with respiratory conditions can lead to life threatening, if not fatal, 
respiratory acidosis [ Austin et al, 2010; Perrin et al, 2011; Wijesinghe et al, 2012].  
This injudicious use of oxygen, often in the pre-hospital setting, has been 
attributed to a number of mechanisms [New, 2006; BTS, 2008] arguably one of the 
most important being release of hypoxic pulmonary vasoconstriction. When ‘at risk’ 
individuals, namely those with type II hypercapnic respiratory failure, are 
administered high flow oxygen this vasoconstriction is released and ventilation 
perfusion matching is worsened and a mismatch is created; resulting in increased 
dead space, further hypercapnia and respiratory acidosis. Other risks to patients 
receiving excessive oxygen include absorption atelectasis, reduced cardiac output, 
damage from oxygen free radicals and increased systemic vascular resistance [BTS, 
2008]. Increasing awareness of these detrimental effects of oxygen [Singhal, 2006; 
Shuvy et al, 2013] have also heralded recent changes in the UK for first response 
management of other clinical conditions such as stroke and cardiac ischeamia 
[JRCALC, 20013].  
In order to address the risk of worsening hypercapnia Campbell in 1960 
advocated small increments of oxygen to correct hypoxaemia. Campbell’s main 
argument was not about limiting the dose but rather ‘advocating care and precision’ 
in contrast to ‘haphazard and imprecise dosage’; claiming controlled evidence should 
Oxygen Therapy: Time to move on?  
 
13 | P a g e  
not be required to prove this [Campbell, 1963].  But this lack of empirical evidence 
regarding low dose oxygen has potentially contributed to the perpetuation and 
continuation of uncontrolled administration of oxygen to the present day.   
In 1962 it was recognised that hypoxaemia, for patients with respiratory 
acidosis, is more profound following treatment with intermittent oxygen, with 
accompanying hypercapnia and lowering of pH [Massaro et al, 1962]. This finding 
supported agreement that continuous administration using low flow rates with graded 
increases avoids serious worsening of hypercapnia while maintaining acceptable 
oxygen tensions. A philosophy echoed today in emergency oxygen guidelines [BTS, 
2008; JRCALC, 2013].  
Further evidence supporting the judicious use of oxygen therapy was 
advocated by Hutchinson in 1964, suggesting that an arterial oxygen tension of 50 
mmHg (7kPa) would prevent death from hypoxia in patients with respiratory failure. 
The use of blood gases was advocated to distinguish respiratory failure from 
breathlessness per se, and, recognising the dangers of withdrawing oxygen 
suddenly from hypercapnic patients, recognised today as rebound hypoxaemia 
(Kane et al, 2011), advice was given never to stop oxygen suddenly. Despite revised 
guidance [BTS, 2008; JRCALC, 2013], abrupt removal of oxygen when hypercapnia 
is suspected is a practice that persists today.  
From these early discoveries regarding the utility and futility of oxygen the 
need for evidence based clinical trials emerged. In particular two landmark trials: 
Nocturnal Oxygen Therapy Trial (NOTT, 1980) and the Medical Research Council 
(MRC, 1981), confirmed that survival in chronic hypoxic COPD (chronic obstructive 
pulmonary disease) is increased with oxygen when compared to no oxygen, survival 
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is better at 15 hours than 12, but maximum survival benefit was achieved at 24 hours 
per day. This evidence provided the contemporary guidance and criteria for the 
prescription of LTOT (long term oxygen therapy) used today (BNF, 2014).    
Whether these early trials in fact hindered clinical progress with oxygen as a 
therapeutic intervention remains debatable. Many questions remained unanswered 
following these trials and it is likely that controversies regarding the use of Long 
Term Oxygen Therapy (LTOT) permeated clinical practice (Heffner, 2013). 
Additionally the findings are often extrapolated to other disease areas such as heart 
failure when LTOT is often prescribed to correct chronic hypoxia. Nonetheless LTOT 
remains one of only two proven interventions that prolong survival in COPD 
(smoking cessation being the other). An on-going multicentre longitudinal trial: Long-
Term Oxygen Treatment Trial (LOTT) is due to complete in December 2015 (NHLBI, 
2013) which should answer some outstanding questions such as effect on 
exacerbation frequency, impact on exercise tolerance, enhancing quality of life and 
impact on mortality.  
Time to Move On  
 Oxygen as a cornerstone to medical therapy is now long established. With 
this integration into mainstream medicine however many fixed beliefs, myths and 
entrenched practice have evolved and become embedded. It is evident however 
from emerging clinical trials that some of these practices are at best of no benefit 
and at worst detrimental to the patient’s clinical outcome. In order to address these 
issues practice must change. This will require a paradigm shift for healthcare 
professionals across clinical settings and clearly education will be crucial to initiating 
this change. It has been proposed that as part of this educational strategy healthcare 
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professionals need to have a greater understanding of the dangers and mechanisms 
that underlie hypercapnia (New, 2006). Beasley et al (2006) suggest that this might 
be achieved by a change in emphasis in teaching the physiology of the carriage of 
oxygen, and rather than focusing on the ‘slippery slope’ the emphasis should be on 
how oxygen tensions can remain relatively stable despite the decline of 
oxyheamoglobin saturation. It is further argued that clinical teaching should present 
not only the adverse physiological effects of hyperoxia but also the potential risks of 
high flow oxygen masking deterioration in a patient’s clinical condition (Beasley et al, 
2007).  
In addition to changing the mindset of healthcare professionals, expectations 
of patients, carers and the general public also need to modified in order to change 
the automatic ‘want’ for oxygen. The influence of the media will be important in 
altering perceptions but by far the most influential catalyst will be the actions and 
responses of healthcare professionals. In order to achieve this clinicians will need to 
think more carefully about how they use oxygen and follow disease and situation-
specific guidelines. Of particular importance is the overarching message that oxygen 
should be titrated to haemoglobin saturation, giving enough but not too much, thus 
avoiding the deleterious effects of both hypoxaemia and hyperoxaemia.  Education 
of clinicians will be the fulcrum to initiate these changes. 
Summary  
Oxygen can be considered as an effective therapeutic intervention in many 
clinical situations [Cranston et al, 2005; BTS, 2008; JRCALC, 2013] , but also one of 
the most misused and abused remedies in medicine. Although it has been inferred 
that evolution has, over several millions of years, evolved to protect us from the toxic 
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effects of oxygen, there has been an assumption that oxygen was the panacea for 
numerous clinical presentations. This historical overview outlines potential 
ambiguities and myths that have permeated clinical and social contexts. Boxes 1 and 
2 summarise these key assertions and contentions of dogma versus science within 
oxygen doctrine. 
Box 1 – Dates of Key Assertions: The Dogma  
 
 
 
 
 
Box 2 – Dates of Key Assertions: The Science 
 
 
 
 
 
Oxygen as a therapy evolved based on individual cases rather than sound 
experimental research. This often led to a priori knowledge being adopted and the 
need for controlled trials diminished. The contribution that the early scientists of the 
18th, 19th & 20th centuries made to establishing oxygen as a medical therapy is 
undisputed. Whether they unwittingly made additional contributions by establishing 
1774 – oxygen as a placebo  
1793 – oxygen is harmless 
1857 – oxygen as a panacea  
1891 – oxygen for dyspnoea 
1939 – 100% oxygen for all 
1849 –toxicity of oxygen recognised 
1890 – judicious employment advocated 
1920 – just enough to relieve hypoxia  
1920 – PRN use of oxygen  ‘useless’ 
1922 – balance the risks of hypoxia & hypercapnia  
1962 – abrupt withdrawal worsens hypercapnia 
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widely held beliefs that oxygen can treat disease and improve health far beyond 
scientific evidence, remains an enigma.  
Perhaps it was the insidious nature of the emergence of oxygen as a therapy 
that led to an eagerness to embrace comparatively unsound evidence. Based on 
presumptions that hypoxia is harmful and that prevention is better than cure, the 
widespread use of oxygen was encouraged and the legacy for today’s practice 
established, some aspects of which have changed very little over the past two 
hundred years. New research in this area, both physiological and clinical, will further 
understanding of the safe use of oxygen, underpinning the futility, and potential 
dangers of widespread injudicious use.  
Meanwhile it is important that clinicians reconsider their practice to reflect 
current guidelines. Important messages have emerged from this historical analysis 
suggesting that the common culture that exists with regards to oxygen is grounded in 
history. As advancements are made regarding emerging therapies for respiratory 
disease it is also an opportunity to reflect and learn from the past. With an emerging 
new evidence base it is time to realign beliefs and alter common practices 
concerning oxygen as a therapeutic intervention in order to ensure patient safety.  
It’s time to move on. 
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